Spots Global Cancer Trial Database for Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors

Official Title: Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors

Study ID: NCT04675320

Conditions

Ovarian Cancer

Interventions

blood samples

Study Description

Brief Summary: This study concerns the creation of a biological collection (blood samples) in patients with Epithelial Ovarian Cancer in in order to describe the immune response with PARP inhibitors.

Detailed Description: The aim is to assess the impact of anti-PARP on peripheral immune populations and the amount of DNA circulating; to correlate these data with tumor infiltration, with the initial clinical characteristics and with the clinical course; compare the immunogenic effect of different anti-PARPs.